The effects of withdrawing tegaserod treatment in comparison with continuous treatment in irritable bowel syndrome patients with abdominal pain/discomfort, bloating and constipation: a clinical study

K D Bardhan; A Forbes; C L Marsden; T Mason; G Short

doi:10.1111/j.1365-2036.2004.02032.x

The effects of withdrawing tegaserod treatment in comparison with continuous treatment in irritable bowel syndrome patients with abdominal pain/discomfort, bloating and constipation: a clinical study

K D Bardhan, A Forbes, C L Marsden, T Mason, G Short

Research output: Contribution to journal › Article › peer-review

19 Citations (Scopus)

Abstract

The post-withdrawal characteristics of tegaserod treatment in patients with irritable bowel syndrome with constipation remain undefined.

Original language	English
Pages (from-to)	213-222
Number of pages	10
Journal	Alimentary Pharmacology and Therapeutics
Volume	20
Issue number	2
DOIs	https://doi.org/10.1111/j.1365-2036.2004.02032.x
Publication status	Published - 15 Jul 2004

Keywords

Abdominal Pain
Adolescent
Adult
Aged
Constipation
Female
Flatulence
Gastrointestinal Agents
Humans
Indoles
Irritable Bowel Syndrome
Male
Middle Aged
Recurrence
Treatment Outcome
Withholding Treatment

Access to Document

10.1111/j.1365-2036.2004.02032.x

Cite this

Bardhan, K. D., Forbes, A., Marsden, C. L., Mason, T., & Short, G. (2004). The effects of withdrawing tegaserod treatment in comparison with continuous treatment in irritable bowel syndrome patients with abdominal pain/discomfort, bloating and constipation: a clinical study. Alimentary Pharmacology and Therapeutics, 20(2), 213-222. https://doi.org/10.1111/j.1365-2036.2004.02032.x

@article{912cbf42ed554c209677bf1e04d3f4a3,

title = "The effects of withdrawing tegaserod treatment in comparison with continuous treatment in irritable bowel syndrome patients with abdominal pain/discomfort, bloating and constipation: a clinical study",

abstract = "The post-withdrawal characteristics of tegaserod treatment in patients with irritable bowel syndrome with constipation remain undefined.",

keywords = "Abdominal Pain, Adolescent, Adult, Aged, Constipation, Female, Flatulence, Gastrointestinal Agents, Humans, Indoles, Irritable Bowel Syndrome, Male, Middle Aged, Recurrence, Treatment Outcome, Withholding Treatment",

author = "Bardhan, {K D} and A Forbes and Marsden, {C L} and T Mason and G Short",

year = "2004",

month = jul,

day = "15",

doi = "10.1111/j.1365-2036.2004.02032.x",

language = "English",

volume = "20",

pages = "213--222",

journal = "Alimentary Pharmacology and Therapeutics",

issn = "0269-2813",

publisher = "Wiley",

number = "2",

}

Bardhan, KD, Forbes, A, Marsden, CL, Mason, T & Short, G 2004, 'The effects of withdrawing tegaserod treatment in comparison with continuous treatment in irritable bowel syndrome patients with abdominal pain/discomfort, bloating and constipation: a clinical study', Alimentary Pharmacology and Therapeutics, vol. 20, no. 2, pp. 213-222. https://doi.org/10.1111/j.1365-2036.2004.02032.x

The effects of withdrawing tegaserod treatment in comparison with continuous treatment in irritable bowel syndrome patients with abdominal pain/discomfort, bloating and constipation: a clinical study. / Bardhan, K D; Forbes, A; Marsden, C L et al.

In: Alimentary Pharmacology and Therapeutics, Vol. 20, No. 2, 15.07.2004, p. 213-222.

Research output: Contribution to journal › Article › peer-review

TY - JOUR

T1 - The effects of withdrawing tegaserod treatment in comparison with continuous treatment in irritable bowel syndrome patients with abdominal pain/discomfort, bloating and constipation: a clinical study

AU - Bardhan, K D

AU - Forbes, A

AU - Marsden, C L

AU - Mason, T

AU - Short, G

PY - 2004/7/15

Y1 - 2004/7/15

N2 - The post-withdrawal characteristics of tegaserod treatment in patients with irritable bowel syndrome with constipation remain undefined.

AB - The post-withdrawal characteristics of tegaserod treatment in patients with irritable bowel syndrome with constipation remain undefined.

KW - Abdominal Pain

KW - Adolescent

KW - Adult

KW - Aged

KW - Constipation

KW - Female

KW - Flatulence

KW - Gastrointestinal Agents

KW - Humans

KW - Indoles

KW - Irritable Bowel Syndrome

KW - Male

KW - Middle Aged

KW - Recurrence

KW - Treatment Outcome

KW - Withholding Treatment

U2 - 10.1111/j.1365-2036.2004.02032.x

DO - 10.1111/j.1365-2036.2004.02032.x

M3 - Article

C2 - 15233702

VL - 20

SP - 213

EP - 222

JO - Alimentary Pharmacology and Therapeutics

JF - Alimentary Pharmacology and Therapeutics

SN - 0269-2813

IS - 2

ER -